Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.

Nissar A Darmani1

  • 1Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.

Methods in Molecular Medicine
|March 2, 2006
PubMed
Summary

Cannabinoids, including delta9-tetrahydrocannibinol (delta9-THC), inhibit gastrointestinal functions like motility and secretion via CB1 receptors. Endocannabinoids also play a key role in regulating these digestive processes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cannabinoid CB<sub>1</sub> Receptor Inverse Agonist/Antagonist SR141716A Activates the Adenylate Cyclase/PKA Signaling Pathway Among Other Intracellular Emetic Signals to Evoke Vomiting in Least Shrews (<i>Cryptotis parva</i>).

International journal of molecular sciences·2025
Same author

Ultra-low doses of methamphetamine suppress 5-hydroxytryptophan-induced head-twitch response in mice during aging.

Behavioural pharmacology·2024
Same author

A Comparative Study of the Antiemetic Effects of α<sub>2</sub>-Adrenergic Receptor Agonists Clonidine and Dexmedetomidine against Diverse Emetogens in the Least Shrew (<i>Cryptotis parva</i>) Model of Emesis.

International journal of molecular sciences·2024
Same author

RNA sequencing least shrew (<i>Cryptotis parva</i>) brainstem and gut transcripts following administration of a selective substance P neurokinin NK<sub>1</sub> receptor agonist and antagonist expands genomics resources for emesis research.

Frontiers in genetics·2023
Same author

Effects of low-doses of methamphetamine on d-fenfluramine-induced head-twitch response (HTR) in mice during ageing and c-fos expression in the prefrontal cortex.

BMC neuroscience·2023
Same author

Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (<i>Cryptotis parva</i>).

Frontiers in pharmacology·2022

Area of Science:

  • Neurogastroenterology
  • Pharmacology

Background:

  • Gastrointestinal functions are regulated by complex neurotransmitter receptor systems.
  • Cannabinoids are known to influence various physiological processes, including those in the gut.

Purpose of the Study:

  • To describe the physiological mechanisms controlling gastrointestinal functions.
  • To review techniques for studying cannabinoid effects on the gastrointestinal tract.
  • To elucidate the role of cannabinoid receptors in gut motility, secretion, feeding, and emesis.

Main Methods:

  • Utilized isolated gastrointestinal muscle preparations and whole animal models.
  • Employed specific cannabinoid receptor antagonists (SR141716A for CB1, SR144528 for CB2).
  • Investigated effects of exogenous cannabinoids (delta9-THC) and endocannabinoids (anandamide, 2-AG).

Related Experiment Videos

Main Results:

  • Exogenous cannabinoids and delta9-THC inhibit gastrointestinal motility, peristalsis, defecation, and secretions via CB1 receptors.
  • Cannabinoids reduce vomiting induced by various stimuli.
  • Cannabinoids often induce hyperphagia (increased appetite).
  • Administration of the CB1 antagonist SR141716A reversed cannabinoid effects and produced opposite effects, indicating endogenous cannabinoid involvement.
  • Endocannabinoids like anandamide and 2-arachidonoylglycerol (2-AG) are present in the gastrointestinal tract and influence its functions.

Conclusions:

  • Cannabinoid CB1 receptors are critical mediators of gastrointestinal functions.
  • Endocannabinoids play a significant role in regulating gut motility, secretion, feeding, and emesis.
  • Anandamide may reduce motility and secretion while promoting feeding, and potentially has antiemetic properties, whereas 2-AG is an emetogen.